AR039983A1 - Derivados de hidroxi tetrahidro-naftalenilurea - Google Patents

Derivados de hidroxi tetrahidro-naftalenilurea

Info

Publication number
AR039983A1
AR039983A1 ARP030101614A ARP030101614A AR039983A1 AR 039983 A1 AR039983 A1 AR 039983A1 AR P030101614 A ARP030101614 A AR P030101614A AR P030101614 A ARP030101614 A AR P030101614A AR 039983 A1 AR039983 A1 AR 039983A1
Authority
AR
Argentina
Prior art keywords
alkyl
halogen
amino
optionally substituted
tri
Prior art date
Application number
ARP030101614A
Other languages
English (en)
Spanish (es)
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of AR039983A1 publication Critical patent/AR039983A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/32Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/17Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/40Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by nitrogen atoms not being part of nitro or nitroso groups
ARP030101614A 2002-05-08 2003-05-08 Derivados de hidroxi tetrahidro-naftalenilurea AR039983A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0210512.0A GB0210512D0 (en) 2002-05-08 2002-05-08 Tetrahydro-napthalene derivatives
GBGB0227262.3A GB0227262D0 (en) 2002-05-08 2002-11-21 Tetrahydro-naphthalene derivatives

Publications (1)

Publication Number Publication Date
AR039983A1 true AR039983A1 (es) 2005-03-09

Family

ID=9936269

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP030101614A AR039983A1 (es) 2002-05-08 2003-05-08 Derivados de hidroxi tetrahidro-naftalenilurea

Country Status (13)

Country Link
KR (1) KR101000688B1 (ko)
AR (1) AR039983A1 (ko)
CU (1) CU23422B7 (ko)
DO (1) DOP2003000642A (ko)
EC (1) ECSP045413A (ko)
GB (2) GB0210512D0 (ko)
GT (1) GT200300102A (ko)
MA (1) MA30728B1 (ko)
MY (1) MY155011A (ko)
PE (1) PE20040363A1 (ko)
PT (1) PT1506167E (ko)
UA (1) UA77301C2 (ko)
ZA (1) ZA200408993B (ko)

Also Published As

Publication number Publication date
MA30728B1 (fr) 2009-10-01
KR20040108784A (ko) 2004-12-24
PE20040363A1 (es) 2004-07-03
DOP2003000642A (es) 2003-11-15
CU23422B7 (es) 2009-09-08
ECSP045413A (es) 2005-01-03
GB0210512D0 (en) 2002-06-19
ZA200408993B (en) 2006-01-25
PT1506167E (pt) 2007-12-10
UA77301C2 (en) 2006-11-15
GT200300102A (es) 2004-03-17
MY155011A (en) 2015-08-28
KR101000688B1 (ko) 2010-12-10
GB0227262D0 (en) 2002-12-31

Similar Documents

Publication Publication Date Title
CL2019001988A1 (es) Compuestos químicos como inhibidores de actividad interleuquina-2.
CR8649A (es) Derivados de formamidina para el tratamiento de enfermedades
PA8621901A1 (es) Derivados de sulfonamida para el tratamiento de enfermedades
DOP2010000148A (es) Derivados bis-(sulfonilzmino) en terapia 066
CL2023001738A1 (es) Inhibidores de prmt5
PA8557501A1 (es) Benzamida, heteroarilamida y amidas inversas
GT200200272A (es) Formas de sal e-2-metoxi-n-(3-{4-[3-metil-4-(6-metilpiridin-3-iloxi) fenilamino] quinazolin-6-il} alil)acetamidayprocedimiento para la produccion
UY27872A1 (es) Inhibidores de caspasa y usos de los mismos.
PA8604301A1 (es) Derivados de 2-amino-piridina utiles para el tratamiento de enfermedades
DOP2003000565A (es) Esteres hidroxamato del acido n-(4-fenil sustituido)- antranilico
HN2003000039A (es) 2-(PIRIMIDIN-2-ILAMINO)-PIRIDO[2,3-d]PIRIMIDIN-7-ONAS
ECSP088869A (es) Derivados de 2-pirazinona para el tratamiento de enfermedades o condiciones en donde resulta beneficiosa la inhibición de la actividad de la elastasa neutrofílica
PA8604201A1 (es) Derivados de 2-amino-piridina utiles para el tratamiento de enfermedades
HK1082946A1 (en) Hydroxy tetrahydro-naphthalenyurea derivatives
DK1569896T3 (da) Tetrahydronaphthalenderivater
ECSP034810A (es) Derivados heterociclilalcoxi-, -alquiltio- y - alquilaminobenzazol tales como ligandos 5-hidroxitriptamina-6
PA8603001A1 (es) Compuestos utiles para el tratamiento de enfermedades
CR9183A (es) Tiazolidinonas metasustituidas, su preparacion y su uso como medicamento
CL2010001566A1 (es) Compuesto derivado de piperidinilo, modulador de la actividad de los receptores de la quimiocina; composicion farmaceutica que los comprende; y su uso en el tratamiento de enfermedades inflamatorias, alergicas, autoinmune.
CL2022001741A1 (es) Compuestos cíclicos y métodos de uso de estos
CO2020006789A2 (es) Procedimiento para la preparación de (3s)-3-(4-cloro-3-{[(2s,3r)-2-(4-clorofenil)-4,4,4-trifluor-3-metilbutanoil]amino}fenil)-3-ácido ciclopropilpropanoico y su forma cristalina para uso como principio activo farmacéutico
DK1572632T3 (da) Tetrahydro-naphthalenderivater som vanilloidreceptorantagonister
UY28993A1 (es) Tetrahidroisoquinolinas sustituidas en calidad de inhibidores de mpm, procedimiento para su uso como medicamento.-
AR039983A1 (es) Derivados de hidroxi tetrahidro-naftalenilurea
UY27794A1 (es) Derivados de hidroxi tetrahidro-naftalenilurea

Legal Events

Date Code Title Description
FG Grant, registration